Disney Shareholders Vote Against Anti-Trans and Detransition Care Proposals

In a landmark annual meeting, Disney shareholders rejected proposals aimed at limiting gender-affirming care and requiring detransition support, affirming the company's inclusive policies.

• At Disney's contentious annual shareholder meeting, proposals from conservative groups to limit gender-affirming care and require detransition support were overwhelmingly rejected.
• Chloe Cole, a political detransitioner, presented a proposal on behalf of conservative groups, advocating for Disney to cover detransitioning care, claiming discrimination under federal regulations.
• Disney's board recommended voting against these proposals, emphasizing their commitment to diversity, equity, and inclusion, and their history of supporting LGBTQ+ rights.
• Critics, including Chloe Cole, accuse Disney of promoting 'transgender ideology' and ignoring the medical needs of detransitioners, a claim Disney's board disputes.
• Despite opposition, contemporary medical evidence suggests that detransition and regret among transgender individuals are exceedingly rare, with satisfaction rates for gender-affirming surgeries remaining high.

4 Articles

Washington Examiner HuffPost Townhall Townhall